BIO International Convention 2025

Trailhead Biosystems

June 16-19, 2025
Boston Convention & Exhibition Center

Book a MeetingConference Details
BIO 2025 HubSpot Header
BIO 2025 Headshots

Meet the team!

Caroline Lawrence Oliver
Senior IP Strategist and Associate Counsel

Josh Snow, PhD
Chief Commercial Officer

Jan Jensen,PhD
Chief Scientific Officer

Explore Elevate's capabilities

We have all the tools you need to run an effective marketing strategy

Content creation

Write a brief description of the product's capabilities

Analytics and reporting

Write a brief description of the product's capabilities

Messaging

Write a brief description of the product's capabilities

Integrations

Write a brief description of the product's capabilities

Automation and workflows

Write a brief description of the product's capabilities

Campaign scheduling

Write a brief description of the product's capabilities

AI Agents

Write a brief description of the product's capabilities

Cross channel distribution

Write a brief description of the product's capabilities

VLMC_Icon

TrailBio® Vascular
Leptomeningeal Cells

Our TrailBio® Vascular Leptomeningeal Cells (VLMCs) are iPSC-derived fibroblast-like cells that form a critical component of the blood-brain barrier. Developed using our proprietary HD-DoE® platform, these neuroectoderm-derived cells line blood vessels in the subarachnoid space alongside pericytes, expressing specific markers that confirm their unique identity and function—ideal for blood-brain barrier interface studies.

More about our latest product release

Our Current Portfolio

Launched

TrailBio® Pre-Myelinating Oligodendrocytes Kit

See more

Launched

TrailBio® Vascular Leptomeningeal Cells

See more

Upcoming Launch

TrailBio® A9 Dopaminergic Neurons

See more